Literature DB >> 11747263

Congenital central hypoventilation syndrome associated with Hirschsprung's disease and neuroblastoma: case of multiple neurocristopathies.

Tilman Rohrer1, Daniel Trachsel, Gabriele Engelcke, Jürg Hammer.   

Abstract

We report on a male infant with the rare combined occurrence of congenital central hypoventilation syndrome (CCHS or Ondine's curse), Hirschsprung's disease (HD), and neuroblastoma. Current therapeutical options leave no doubt that children with isolated forms of CCHS, HD, or neuroblastoma must be treated, but management decisions and the ethical dilemma become more difficult with the presence of multiple neurocristopathies. Our patient was dependent on mechanical ventilation and total parenteral nutrition, when a neuroblastoma was diagnosed at age 5 months. We initiated an attempt at curative chemotherapy. The tumor failed to respond to recommended chemotherapeutic regimens, and the patient died at 11 months of age. We emphasize the importance of screening CCHS patients for associated illnesses such as neuroblastoma and ganglioneuroblastoma at time of diagnosis. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 11747263     DOI: 10.1002/ppul.10031

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  14 in total

1.  Congenital central hypoventilation syndrome with hyperinsulinism in a preterm infant.

Authors:  Ulrike Hennewig; Berit Hadzik; Markus Vogel; Thomas Meissner; Timm Goecke; Hartmut Peters; Georg Selzer; Ertan Mayatepek; Thomas Hoehn
Journal:  J Hum Genet       Date:  2008-03-14       Impact factor: 3.172

2.  Haddad syndrome--congenital central hypoventilation associated with Hirschsprung's disease.

Authors:  Susan D'Souza; R P Khubchandani
Journal:  Indian J Pediatr       Date:  2003-07       Impact factor: 1.967

3.  PHOX2B genotype allows for prediction of tumor risk in congenital central hypoventilation syndrome.

Authors:  Delphine Trochet; Louise M O'Brien; David Gozal; Ha Trang; Agneta Nordenskjöld; Béatrice Laudier; Pär-Johan Svensson; Sabine Uhrig; Trevor Cole; Stephan Niemann; Arnold Munnich; Claude Gaultier; Stanislas Lyonnet; Jeanne Amiel
Journal:  Am J Hum Genet       Date:  2005-01-18       Impact factor: 11.025

4.  Central Alveolar Hypoventilation Syndromes.

Authors:  Hiren Muzumdar; Raanan Arens
Journal:  Sleep Med Clin       Date:  2008-12-01

5.  Anesthetic management of a child with congenital central hypoventilation syndrome (CCHS, Ondine's curse) for dental treatment.

Authors:  Hajime Ishibashi; Koji Umezawa; Sachiyo Hayashi; Koh Shibutani
Journal:  Anesth Prog       Date:  2004

6.  Cerebral MRI abnormalities in a premature infant with later confirmed congenital central hypoventilation syndrome.

Authors:  Eveline van Delft; Peter Andriessen; Colleen N A L Vaessens; Jan Buijs; Sidarto Bambang Oetomo
Journal:  Eur J Pediatr       Date:  2009-12-02       Impact factor: 3.183

7.  A case of congenital central hypoventilation syndrome with PHOX2B gene mutation in a Korean neonate.

Authors:  Kyoung-Ah Kwon; Su-Eun Park; Shin-Yun Byun; Shine-Young Kim; Sang-Hyoun Hwang
Journal:  J Korean Med Sci       Date:  2010-07-20       Impact factor: 2.153

8.  Autonomic neurocristopathy-associated mutations in PHOX2B dysregulate Sox10 expression.

Authors:  Mayumi Nagashimada; Hiroshi Ohta; Chong Li; Kazuki Nakao; Toshihiro Uesaka; Jean-François Brunet; Jeanne Amiel; Delphine Trochet; Teruhiko Wakayama; Hideki Enomoto
Journal:  J Clin Invest       Date:  2012-08-27       Impact factor: 14.808

9.  Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma.

Authors:  Delphine Trochet; Franck Bourdeaut; Isabelle Janoueix-Lerosey; Anne Deville; Loïc de Pontual; Gudrun Schleiermacher; Carole Coze; Nicole Philip; Thierry Frébourg; Arnold Munnich; Stanislas Lyonnet; Olivier Delattre; Jeanne Amiel
Journal:  Am J Hum Genet       Date:  2004-03-11       Impact factor: 11.025

10.  Myc proteins as therapeutic targets.

Authors:  W C Gustafson; W A Weiss
Journal:  Oncogene       Date:  2010-01-25       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.